Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01208844 · ClinicalTrials.gov registry record

Study of Physical Health for Women With Posttraumatic Stress or Depression

A clinical trial, sponsored by Nova Southeastern University.

Completed
Registry status
59
Enrollment target

NCT01208844: Completed study, sponsored by Nova Southeastern University.

NCT01208844 is a clinical trial that has completed, run by Nova Southeastern University. The registered enrollment target is 59 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01208844 has completed, sponsored by Nova Southeastern University.

COMPLETED
Registry status
59 participants
Enrollment target

Study Summary

The purpose of this study is to obtain a better understanding of how stress is related to health risks.

Primary Outcome

This primary outcome will be assessed at the second study visit (1-7 days from first study visit for those who are eligible).

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2008-06
Est. Completion 2012-08
Nova Southeastern University

71 total trials

What the finished NCT01208844 record still lists

NCT01208844 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 59 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01208844 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01208844 about?

NCT01208844 is a clinical study titled "Study of Physical Health for Women With Posttraumatic Stress or Depression". The purpose of this study is to obtain a better understanding of how stress is related to health risks.

What is the current status of trial NCT01208844?

This trial is currently completed. The enrollment target is 59 participants. The study started on 2008-06. Estimated completion is 2012-08.

Who is sponsoring clinical trial NCT01208844?

This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03801083 · 59 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers

  • NCT04332367 · 59 participants · Phase 2

    Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance

  • NCT05489575 · 59 participants · NA

    CPAP for the Treatment of Supine Hypertension

  • NCT06721689 · 59 participants · Phase 1

    PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01208844, the US trial registry maintained by the National Library of Medicine. NCT01208844 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.